Annemilaï Tijeras-Raballand Selected Research

Annemilaï Tijeras-Raballand Research Topics

Disease

20	Neoplasms (Cancer) 12/2023 - 04/2010
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2010
4	Carcinogenesis 03/2021 - 06/2013
3	Adenocarcinoma 12/2022 - 11/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 05/2013
2	Colonic Neoplasms (Colon Cancer) 12/2015 - 04/2011
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Squamous Cell Carcinoma of Head and Neck 09/2022
1	Disease Progression 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Neoplasm Metastasis (Metastasis) 03/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2013
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2013
1	Melanoma (Melanoma, Malignant) 12/2013
1	Glioblastoma (Glioblastoma Multiforme) 12/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Primitive Neuroectodermal Tumors (PNET) 09/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2012
1	Peritoneal Neoplasms 04/2011
1	Carcinoma (Carcinomatosis) 04/2011
1	Ascites 04/2011

Drug/Important Bio-Agent (IBA)

4	Everolimus FDA Link 09/2022 - 09/2012
3	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2013
3	Sunitinib (Sutent)FDA Link 06/2016 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 05/2021 - 11/2015
2	Leucovorin (Folinic Acid)FDA Link 01/2019 - 12/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 12/2015
2	CarcinogensIBA 03/2015 - 04/2010
2	Galectin 1 (LGALS1)IBA 09/2014 - 03/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2014 - 06/2013
2	Phosphotransferases (Kinase)IBA 02/2014 - 05/2013
2	MTOR InhibitorsIBA 05/2013 - 09/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 04/2010
1	PeriostinIBA 12/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	afliberceptIBA 01/2019
1	Axitinib (AG 013736)IBA 06/2016
1	Dihydrotachysterol (AT 10)IBA 12/2015
1	Fluorouracil (Carac)FDA LinkGeneric 12/2015
1	Adenosine Triphosphate (ATP)IBA 08/2015
1	LY-2157299IBA 08/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2015
1	Glutamine (L-Glutamine)FDA Link 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 09/2014
1	compound 0118IBA 09/2014
1	saccharide-binding proteinsIBA 09/2014
1	MitogensIBA 02/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2014
1	Cysteine (L-Cysteine)FDA Link 12/2013
1	AcidsIBA 12/2013
1	Sirolimus (Rapamycin)FDA Link 05/2013
1	temsirolimus FDA Link 05/2013
1	LigandsIBA 12/2012
1	VimentinIBA 12/2012
1	Chemokine ReceptorsIBA 12/2012
1	TOR Serine-Threonine KinasesIBA 09/2012
1	Angiogenesis InhibitorsIBA 09/2012
1	neurotrophin 4IBA 04/2011
1	AntibodiesIBA 04/2010
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2010

Therapy/Procedure

12	Therapeutics 09/2022 - 04/2010
2	Drug Therapy (Chemotherapy) 09/2022 - 03/2021
1	Immunotherapy 12/2023
1	Induction Chemotherapy 09/2022
1	Adjuvant Chemotherapy 12/2015